Related Experiment Video
Updated: May 15, 2026
08:01
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
The Norwegian Multiple Sclerosis Registry and Biobank
K-M Myhr1, N Grytten, J H Aarseth
1Norwegian Multiple Sclerosis Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway. kjmy@haukeland.no
Acta Neurologica Scandinavica. Supplementum
|January 3, 2013
Summary
The Norwegian Multiple Sclerosis Registry and Biobank collects clinical and biological data to advance understanding of multiple sclerosis (MS) pathogenesis. This resource facilitates research for improved disease management and patient care.
Area of Science:
- Neurology
- Immunology
- Epidemiology
Background:
- Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease.
- The exact cause of MS remains unknown.
- Currently, no cure exists for MS, necessitating further research into its pathogenesis.
Purpose of the Study:
- To establish a comprehensive resource for multiple sclerosis research.
- To facilitate the investigation of disease mechanisms.
- To improve healthcare outcomes for individuals with MS.
Main Methods:
- The Norwegian Multiple Sclerosis Registry and Biobank was created for systematic data collection.
- Clinical and epidemiological data are gathered from patients.
- Biological samples are collected with informed patient consent and neurologist recordings.
Main Results:
- The Norwegian Multiple Sclerosis Registry and Biobank provides access to data and biological samples.
- Researchers can access these resources upon application.
Conclusions:
- The Registry and Biobank is a collaborative effort between patients and healthcare professionals.
- It aims to foster research for a better understanding of MS.
- The ultimate goal is to enhance healthcare for multiple sclerosis patients.
